Breaking New Ground: EffePharm’s Liposomal Technology and Anti-Aging Innovations at SSW 2024
2024-11-07 | EffePharm
At SupplySide West 2024 in Las Vegas, the EffePharm team presented its groundbreaking LipoAvail™ liposome technology and innovative products designed to improve nutrient absorption and efficacy. These innovations underscore EffePharm’s commitment to advancing health solutions that address common challenges in the dietary supplement industry, with a particular focus on anti-aging and wellness.
LipoAvail™ Liposomal Technology: Advancing Nutrient Delivery
LipoAvail™ liposome technology is designed to overcome the widespread challenges in nutrient delivery. Active ingredients often face stability issues and poor absorption rates. This technology ensures better stability and improved bioavailability by encapsulating nutrients within protective lipid layers.
For instance, NAD+—a crucial coenzyme for energy production and anti-aging—has traditionally been difficult to absorb effectively. LipoAvail™ technology improves its absorption by up to ninefold in the liver. Additionally, glutathione, an important antioxidant, benefits from an absorption boost of up to 13 times, enhancing its ability to support detoxification and cellular defense mechanisms.
UthPeak™ NMNH: The Next-Generation NAD+ Enhancer
One of EffePharm’s key innovations is UthPeak™ NMNH. UthPeak™ NMNH is a form of reduced NMN (Nicotinamide Mononucleotide), serving as a direct precursor to NAD+, a crucial coenzyme for cellular energy production and longevity. This advanced formula has been shown to boost NAD+ levels by up to tenfold, significantly enhancing cellular energy and supporting the body’s natural anti-aging mechanisms.
Currently, UthPeak™ NMNH is undergoing clinical trials to assess its potential benefits in cardiovascular health, neuroprotection, and metabolic function. As the first NMNH product to earn Self-GRAS (Generally Recognized As Safe) status, UthPeak™ NMNH establishes a new benchmark in the field of NAD+ enhancement.
ErgoX™: Leveraging Ergothioneine for Cellular Health
Another product in EffePharm’s portfolio is ErgoX™ ergothioneine, a naturally occurring antioxidant known for its ability to combat oxidative stress and inflammation. By helping protect cells from oxidative damage, ErgoX™ supports overall health, especially in aging and chronic disease prevention.
The Future of NAD+ Research
During the event, Dr. Yu Jianjun, EffePharm’s R&D Director, and Dr. Richard, Co-Founder of Stanford’s SOLUTION initiative and EffePharm advisory board member, presented the promising future of NAD+ research. They discussed the growing body of evidence supporting the role of NMNH as a next-generation NAD+ enhancer, highlighting its potential to enhance cellular energy, combat age-related decline, and improve overall health outcomes. Their presentation generated strong interest in the industry, emphasizing the importance of ongoing research.
- UthPeak® Reduced NMN (NMNH)
World's First, Largest, and Longest Human Clinical Trial on Reduced NMN (NMNH)Learn more - ErgoX™ Ergothioneine
Targeted Super Antioxidant Against AgeLearn more - Liposomal Silymarin
Silymarin is a natural flavonoid compound derived from milk thistle seeds that contains silybin as its primary active ingredient.Learn more - Liposomal GlutathioneGlutathione is a key antioxidant composed of three amino acids. It serves as an important metabolic regulator within cells.Learn more
Schedule an Appointment with EffePharm's Experts
Reference available upon request.
| These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. |
Information on this site is provided for informational purposes only. It is not meant to substitute for medical advice from your physician or other medical professional. You should not use the information contained herein to diagnose or treat a health problem or disease or prescribe any medication. Carefully read all product documentation. If you have or suspect that you have a medical problem, promptly contact your regular healthcare provider.